Radiation therapy of the liver metastatic disease.
Eight patients with symptomatic liver metastasis from different primary tumours received palliative radiation therapy. Daily doses of 150-200 r calculated in the mid-liver plane were delivered. The total dose employed was 2,500 r given in 3 weeks. Six patients responded good, one reasonable and one patient failed to respond to radiation. Liver function tests and liver scans also reflected the treatment response. All eight patients tolerated the treatment and no mortality due to treatment was recorded.
D000230:Adenocarcinoma / Q000532:radiotherapy; D000328:Adult; D000410:Alanine Transaminase; D001219:Aspartate Aminotransferases; D002648:Child; D003035:Cobalt; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000532:radiotherapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care; D011882:Radiotherapy, High-Energy; D012512:Sarcoma, Ewing / Q000532:radiotherapy; D009396:Wilms Tumor / Q000532:radiotherapy
D003035:Cobalt; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase